We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

79 hedge funds and large institutions have $11.2M invested in Ampio Pharmaceuticals Inc. in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $380K | Put options by funds: $95K

75% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 12

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

62% more capital invested

Capital invested by funds: $6.92M → $11.2M (+$4.32M)

3% more funds holding

Funds holding: 77 → 79 (+2)

Holders
79
Holders Change
+2
Holders Change %
+2.6%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
21
Reduced
12
Closed
6
Calls
$380K
Puts
$95K
Net Calls
+$285K
Net Calls Change
+$117K

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$649K
2
PCMC
Private Capital Management (Colorado)
Colorado
+$308K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$200K
4
BlackRock
BlackRock
New York
+$186K
5
Wells Fargo
Wells Fargo
California
+$98.1K

Top Sellers

Rank Fund Capital Flow
1
AAP
Arax Advisory Partners
Colorado
-$639K
2
HC
HNP Capital
New York
-$200K
3
Citadel Advisors
Citadel Advisors
Florida
-$86K
4
Osaic Holdings
Osaic Holdings
Arizona
-$42.4K
5
WS
Wedbush Securities
California
-$21.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
26
LPL Financial
California
$49K -$13.3K -80 -24%
Charles Schwab
27
Charles Schwab
California
$47K – – –
DIA
28
Dana Investment Advisors
Wisconsin
$41K – – –
RJFSA
29
Raymond James Financial Services Advisors
Florida
$41K +$2.83K +17 +9%
TFS
30
TrustCore Financial Services
Tennessee
$39K +$26.9K +162 +405%
UCFA
31
United Capital Financial Advisors
Texas
$34K +$2K +12 +7%
Wolverine Trading
32
Wolverine Trading
Illinois
$32K +$3.49K +21 +15%
State Street
33
State Street
Massachusetts
$30K – – –
GWM
34
Geneos Wealth Management
Colorado
$28K -$7.15K -43 -22%
MMA
35
Miracle Mile Advisors
California
$25K +$11K +66 +99%
Citadel Advisors
36
Citadel Advisors
Florida
$22K -$86K -517 -82%
JWA
37
JFS Wealth Advisors
Pennsylvania
$22K – – –
HAG
38
HighPoint Advisor Group
Illinois
$19K -$2.99K -18 -15%
KWM
39
Kingsview Wealth Management
Oregon
$19K +$16.8K +101 New
Osaic Holdings
40
Osaic Holdings
Arizona
$17K -$42.4K -255 -74%
Victory Capital Management
41
Victory Capital Management
Texas
$16K -$14.1K -85 -50%
SBIA
42
Sheaff Brock Investment Advisors
Indiana
$16K – – –
CCB
43
Cutter & Co Brokerage
Missouri
$16K +$14.1K +85 New
MAM
44
Marotta Asset Management
Virginia
$15.3K – – –
California Public Employees Retirement System
45
California Public Employees Retirement System
California
$13K – – –
Commonwealth Equity Services
46
Commonwealth Equity Services
Massachusetts
$13K – – –
Morgan Stanley
47
Morgan Stanley
New York
$13K +$1.16K +7 +11%
WP
48
WealthPLAN Partners
Nebraska
$12K – – –
CW
49
CreativeOne Wealth
Kansas
$12K +$3.99K +24 +65%
Brown Advisory
50
Brown Advisory
Maryland
$11K – – –
1
2
3 4

AMPE Hedge Fund Activity: Q2 2020 in Review

79 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2020, worth a combined $11.2M — up 62% from $6.92M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AMPE positions and 6 closed out — a net gain of 4 holders — while 21 added to existing stakes and 12 trimmed.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $649K. The largest seller was Arax Advisory Partners, cutting an estimated $639K.

  • 79 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2020, up from 77 in Q1 2020.
  • Funds reported $11.2M of Ampio Pharmaceuticals Inc. stock for Q2 2020, up 62% quarter-over-quarter.
  • 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2020 and 6 closed out, a net change of +4 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2020 was Bridgeway Capital Management, an estimated $649K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2020 was Arax Advisory Partners, an estimated $639K sold.

Based on aggregated 13F filings for Q2 2020.